News

New SERENADE trial for patients with heart failure
15th December 2017

New SERENADE trial for patients with heart failure

Researchers at the Sheffield Pulmonary Vascular Disease Unit and Clinical Research Facility are participating in a new study for people with a certain type of heart failure. Heart Failure with "Preserved Ejection Fraction" (HFPEF) is a common form...

Read More

New Health Research Authority website
28th November 2017

New Health Research Authority website

The Health Research Authority have launched a new website, containing a range of useful information about planning and conducting clinical and health research in the NHS - see https://www.hra.nhs.uk/

Read More

New framework for UK health and social care research launched
28th November 2017

New framework for UK health and social care research launched

The Health Research Authority and the government published a new policy framework for health and social care research in October 2017. The new guidelines replace separate Research Governance Frameworks in each UK country with a single se...

Read More

Leading research into pulmonary hypertension lands Professor national award
24th October 2017

Leading research into pulmonary hypertension lands Professor national award

Prof David Kiely, Director of the Pulmonary Vascular Disease Unit at Sheffield Teaching Hospitals has received a national research award from the NIHR Clinical Research Network and Royal College of Physicians, for his work in the development ...

Read More

Sheffield team top UK recruiter in IPF trial
12th October 2017

Sheffield team top UK recruiter in IPF trial

Dr Stephen Bianchi and the clinical Research Facility team were the top UK recruiting site for INSTAGE, a clinical trial for people with idiopathic pulmonary fibrosis. @CRFSheffield supported #clinicaltrial in #lungdisease. @SheffieldHosp is the ...

Read More

“REPLACE Trial of Riociguat for Pulmonary Arterial Hypertension
5th September 2017

“REPLACE Trial of Riociguat for Pulmonary Arterial Hypertension

Dr Robin Condliffe and the Royal Hallamshire Clinical Research Facility are starting a trial of Riociguat, a drug for people with Pulmonary Arterial Hypertension (PAH). The trial is sponsored by Bayer PLC. Current PAH treatments include phosphodie...

Read More

STH success in national research league table
18th August 2017

STH success in national research league table

Sheffield Teaching Hospitals has been named in the top ten ‎research active NHS Trusts in the NIHR Research Activity League Table 2016-2017. Last year 11,490 patients took part in clinical research studies in STH, a 34% increase from the previ...

Read More

CF Health Hub Data Observatory
27th July 2017

CF Health Hub Data Observatory

A Quality Improvement project and Trials within Cohort platform for Cystic Fibrosis: The Data Observatory project aims to build on the work of the CFHealthHub and the ACTIF Programme Grant led by a Sheffield research team (Chief Investigators Dr ...

Read More

Cystic Fibrosis Annual Newlstter
27th June 2017

Cystic Fibrosis Annual Newlstter

The Sheffield Adult Cytic Fibrosis Centre has published its annual newsletter: down load it here: http://www.lungsheffield.org/clinical-services/newsletter

Read More

Patient guide to getting involve in clinical research
9th June 2017

Patient guide to getting involve in clinical research

The Sheffield Pulmonary Vascular Disease Unit, in collaboration with the UK Pulmonary Hypertension Association, has produced a guide for patients about getting involved in research, and about the pulmonary vascular research programme in Sheffield....

Read More